By WSJ Staff
Apple $(AAPL)$: The company's net income beat expectations, despite iPhone sales falling in the crucial December quarter. Shares climbed more than 3% in premarket trading.
Intel $(INTC)$: The chip-maker reported a smaller-than-expected decline in quarterly sales, alongside a gloomy outlook. The stock rose almost 2% premarket.
Visa (V): The credit-card company's earnings and revenue outstripped estimates, with Visa citing strong spending during the holiday season. The stock gained 2% before the opening bell.
Vertex Pharmaceuticals $(VRTX)$: Shares in the biopharmaceutical company shot up almost 10% offhours after the Food and Drug Administration approved Vertex's oral non-opioid pain medication, Journavx.
Samsung (KR:005930): The world's largest maker of memory chips and smartphones forecast limited earnings growth in this quarter due to weakening profits in its core semiconductor sector. Samsung shares fell 2.4% in South Korea.
Novartis (CH:NOVN, NVS): The pharmaceutical company forecast further profit and sales growth this year, after beating fourth-quarter expectations. Shares rose 3.5% in Switzerland.
AbbVie $(ABBV)$, Chevron $(CVX)$, Colgate-Palmolive $(CL)$ and Exxon Mobil $(XOM)$ are scheduled to report earnings before U.S. markets open today.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
January 31, 2025 04:59 ET (09:59 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。